Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabilone for Anorexia in Advanced Lung Cancer
NCT02802540Phase 3Unknown
- Start
- Dec 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anorexia nervosa (AN) and cachexia comparing Nabilone Arm with Placebo Arm (2 arms). Primary endpoints: Anorexia Cachexia Scale Score at 8 weeks, Percentage Weight Loss at 8 weeks and 3 more. Status: unknown.
02
Drugs
nabilone
03
Conditions
anorexia nervosa (AN)cachexia
Beyond the preview
Go deeper on NCT02802540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802540.